Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has filed copies of newspaper advertisements published on May 8, 2025 in Financial Express and Jansatta. The notice is addressed to equity shareholders regarding unclaimed equity shares (Final Dividend FY 2017-18) that are due to be transferred to the Investor Education and Protection Fund (IEPF) under Section 124(6) of the Companies Act, 2013. Individual notices have also been sent by post to the concerned shareholders, and details are available on the company's website at www.lalpathlabs.com. The disclosure is made under Regulation 30 and 47 of SEBI's Listing Regulations.
This is a routine regulatory compliance filing with no material impact on the stock price. Shareholders who have unclaimed dividends from FY 2017-18 should take action and file claims before the shares are permanently transferred to the IEPF.